Discovery and development in the pharma and regenerative medicine industries depend on the use of primary human cells. Whether they are guiding our decisions through cell-based assays, or serving as raw material components of products intended for use as implantable therapies, human cells are on the critical path. CYTOStrategy brings our clients over three decades of practical experience in the isolation, characterization, and utilization of primary human cells for in vitro and in vivo applications. Our mission is to help clients develop sound and solvent strategies for acquisition and incorporation of primary human cells into their workflows and product portfolios.
Do you have a challenging cellbio project?
Submit a brief project description in the form below to request a free initial consultation.